Blood Preparation Market 2021 By Industry Trends & Regional Forecast To 2027

Blood Preparation Market 2021 By Industry Trends & Regional Forecast To 2027

The global blood preparation market is poised to record groundbreaking returns in the overall healthcare and medical devices industry, primarily due to the mounting prevalence of vivid chronic diseases and blood related conditions globally. Not to mention, rising awareness pertaining to blood donation in tandem with supportive reforms and efforts being undertaken by governmental authorities of various developing and developed nations to enhance the blood donation campaigns would potentially boost the market share in the upcoming years.

In this context, it is pivotal to mention that global blood preparation market is predicted to record a valuation of USD 75 billion over the span of six years right from 2019 to 2025.

Request for a sample copy of this report @  

Given that a subsequent loss of blood in any form adds to the need for blood preparation, it can be stated that rising incidences of road accidents and increasing trauma cases would drive the industry growth to a much larger extent. As per a credible news source, it was reported that over 40 per cent of total deaths in the 2018 were a primary cause of excessive loss of blood. This calls in for proper techniques and procedures of blood preparation.

However, one of the growth restraining factors is the risk of infection post blood transfusion, which is expected to decline the growth sales to some extent.

An increased prevalence of venous thrombosis and other similar conditions has accelerated the demand for anticoagulant drugs worldwide. As per industry experts, the anticoagulants and antithrombotic segment would observe a stellar remuneration of USD 30 billion by the end of 2025, driven by hefty investments by various companies into research and development field.

For instance, Polysan- a Russian pharmaceutical company had in 2018 announced investing over USD 60 million in establishment of full cycle production of German pharma firm- Bayer’s anticoagulant drug. As per news reports, the production of Xarelto anticoagulant drug would be established at the units of Polysan in St. Petersburg. Such initiatives offer a glimpse of the impending scenario of global blood preparation market.

Request for customization @

Endorsing an expansive application spectrum, blood preparation market is said to be highly characterized by thrombocytosis segment, which captured an overall business share of 25 per cent in 2018, while depicting a notable growth in the upcoming years. A predominant reason adding to dramatic segmental growth is a significant upsurge in incidences of thrombocytosis. It has been revealed that patients suffering from chronic kidney diseases are highly vulnerable to thrombosis, thus producing a demand spurt for anticoagulant drugs globally.

Amidst the intense share battle, the United States is poised to emerge as a prominent hub for blood preparation industry, looking forward to exhibiting a growth rate of 3.1 per cent through 2025. The growth can be credited to high awareness levels in conjugation with rising adoption of aesthetic procedures owing to increased rates od aesthetic therapies and surgeries.

On the other hand, Japan blood preparation market is also likely to depict notable growth over the foreseeable time frame, due to the expanding geriatric population base and governmental initiatives being undertaken by the federal government. For the records, blood preparation industry in Japan acquired a significant stake of USD 4 billion in 2025.

Partial Chapter of the Table of Content

Chapter 2. Executive Summary

2.1. Global blood preparation industry 3600 synopsis, 2014 - 2025

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Application trends

2.1.4.  Regional trends

Chapter 3.  Blood Preparation Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 – 2025

3.3. Industry impact forces

3.3.1.  Growth drivers  Growing prevalence of diseases requiring blood transfusion  Rising applications of blood derivatives  Increasing awareness about blood donations in developing countries      

3.3.2.  Industry pitfalls & challenges  Risk of infection transmission through transfused blood

3.4. Growth potential analysis

3.4.1.  By product

3.4.2.  By application

3.5. Industry eco-system

3.5.1.  Supply chain analysis

3.6. Regulatory landscape

3.6.1.  U.S

3.6.2.  Europe

3.7. Porter’s analysis

3.8. Competitive landscape, 2018

3.8.1.  Strategy dashboard

3.9. PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @